(Microbicide Trials Network) Recognizing the major role personal preferences play in HIV prevention, the National Institutes of Health (NIH)-funded Microbicide Trials Network (MTN) has launched a rectal microbicide study that asks participants to 'try on' potential approaches before actual products are developed. The study, MTN-035, or DESIRE (Developing and Evaluating Short-acting Innovations for Rectal Use), is the first to systematically examine placebo, or inactive, methods for delivering drugs to help prevent HIV from receptive anal sex.
from EurekAlert! - Social and Behavioral Science http://bit.ly/2IsTOyf
No comments:
Post a Comment